Obsessive-Compulsive Disorder Clinical Trial
Official title:
A RCT of a Mobile App (esTOCma) to Improve Mental Health Literacy, Stigmatizing Attitudes Related to OCD, and Confidence in Dealing With Students With OCD in Teachers
The aim of the present study is to assess the efficacy of a mobile application called esTOCma in promoting mental health literacy, reducing stigmatizing attitudes related to the Obsessive-Compulsive Disorder (OCD) and improving teachers' confidence in dealing with students that might have OCD. A parallel, randomized controlled trial with two conditions (experimental and control group) will be carried out in a sample of teachers that work in primary and secondary education. Pre-post changes will be assessed. Experimental group will use the app until they finish it (within a set period of 10 days), whereas control group will do nothing for 10 days. Primarily, it is expected that after the use of the app, participants will show an improvement in OCD-related literacy, stigmatizing attitudes, desired social distance and their comfort, confidence and perceived ability in teaching and handling students with OCD. Secondarily, the investigators hypothesize that experimental group might show a reduction in obsessive-compulsive symptoms.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Inclusion Criteria: - Being a practising teacher in Primary or Secondary education. - Working in the education field as a guidance counsellor, language teacher or therapeutic pedagogue. Exclusion Criteria: - Working in a field other than those mentioned above. - Having less than 18 years old. |
Country | Name | City | State |
---|---|---|---|
Spain | University of Valencia/ Universitat de València | Valencia |
Lead Sponsor | Collaborator |
---|---|
University of Valencia | Ministry of Science and Innovation |
Spain,
Chaves A, Arnaez S, Castilla D, Roncero M, Garcia-Soriano G. Enhancing mental health literacy in obsessive-compulsive disorder and reducing stigma via smartphone: A randomized controlled trial protocol. Internet Interv. 2022 Jul 13;29:100560. doi: 10.1016/j.invent.2022.100560. eCollection 2022 Sep. — View Citation
Garcia-Soriano G, Arnaez S, Chaves A, Del Valle G, Roncero M, Moritz S. Can an app increase health literacy and reduce the stigma associated with obsessive-compulsive disorder? A crossover randomized controlled trial. J Affect Disord. 2024 Apr 1;350:636-647. doi: 10.1016/j.jad.2024.01.168. Epub 2024 Jan 20. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in general OCD literacy | Score change in the knowledge and the attitudes towards obsessive-compulsive disorder measured by the OCD Knowledge Stigma Assessment Scale (OKSAS). It is a self-report ad hoc questionnaire with 24 items and a response scale ranging from 1 "Completely disagree" to 5 "Completely agree". The total score is the sum of the items and higher score indicate more knowledge about the disorder. | Through app completion (an estimation of 10 days). | |
Primary | Change in OCD literacy associated with a vignette | Score change in mental health literacy associated with a vignette assesses by:
An ad hoc questionnaire with 2 items: an open-ended question that inquires about what the participants thinks is happening to the person described in the vignette; and a Likert question "To what extent do you feel capable of helping a student like N?" with a 5-point scale (from 1 "Slightly/Not at all confident" to 5 "Extremely/Very confident". Each item will the reviewed individually. Questionnaire developed by Whitley & Gooderham (2016) composed by 6 items. The 3 items corresponding to Teacher Efficacy, Teacher Expectations and Problem Severity will be used. 4-point Likert scale ranging from 1"Least/Lowest" to 4 "Most/Highest". The total score and each item will be taken into account. There will be two vignettes that will be randomly assigned. Both portray a student with OCD but one focuses on the contamination content, and the other on the aggressive content. |
Through app completion (an estimation of 10 days). | |
Primary | Change in stigmatizing attitudes related to OCD associated with a vignette | Score change in stigma associated with a vignette measured by:
Attribution Questionnaire (AQ-9; González-Sanguino, et al., 2019) is a self-report measure. It has a Likert scale ranging from 1 = "Not at all" to 9 = "Very much". Investigators will not use the items corresponding to Coercion, Pity and Avoidance. The higher the score (total and per item), the higher the stigma. OCD Stigma Measure (OSM; Ponzini et al., 2023) is a self-report measure composed by 16 items and two subscales (Severe Mental Illness-related Stereotypes and Anxiety-relevant Stereotypes). 11 items will be used in this study. A total score (sum of all the items) is interpreted, as well as each subscale. |
Through app completion (an estimation of 10 days). | |
Primary | Change in comfort in addressing OCD | Score change in the comfort in dealing with people with OCD will be measured by Comfort Questionnaire (Kutcher et al., 2016). It is a self-report instrument with two parts. Part A assesses the sense of comfort in talking to, identifying and advising students with OCD, and part B appraises the referrals, that is, whether participants have identified and advised a student or acquaintance who might have OCD, or if they have sought help for themselves. Part A has a Likert scale ranging from 1 "Completely disagree" to 5 "Completely agree" so the total score will be obtained by adding up and averaging these items. And in part B they have to answer Yes or No, therefore each item will be reviewed individually in terms of percentages. | Through app completion (an estimation of 10 days). | |
Primary | Change in desired social distance | Score change in desired social distance will be measured by Reported and Intended Behaviour Scale (RIBS; Evans-Lacko et al., 2011). It is a self-report measure with 8 items and it inquires about Reported and Intended Behaviour among four different contexts: (1) living with, (2) working with, (3) living nearby and (4) continuing a relationship with someone with a mental health problem. Investigators will use the 4 items corresponding to Intended Behaviour subscale. Likert scale from 1 "Agree strongly" to 5 " Disagree strongly" and an additional "Don't know" response option. The total score is calculated by adding together the response values, and "Don't know" is coded as a neutral value (i.e. 3).
This questionnaire will be used in association with a vignette. |
Through app completion (an estimation of 10 days). | |
Secondary | Change in obsessive-compulsive symptoms | Score change in OCD symptoms will be measured by Obsessive-Compulsive Inventory - Revised. The reduced 4-item version (OCI-4; Abramovich et al., 2021) that assesses four dimensions of OCD (washing, checking, ordering, obsessing) will be used. It has a 5-point Likert scale ranging from 0 "Not at all" to 4 "Very much". The items will be added. | Through app completion (an estimation of 10 days). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |